Dexcom | DXCM - الربح قبل الضريبة

سعر السهم
60.35
التغيير اليومي
0.87 1.46%
شهريا
-4.37%
سنويا
-27.59%
Q2 التوقعات
60.07




الربح قبل الضريبة تغيير تاريخ
Abbott USD 2.39B 27M 2026-03
Align Technology USD 148.89M 27.71M 2026-03
AtriCure USD 394K 1.97M 2026-03
Avanos Medical USD 1.2M 2.4M 2025-12
Baxter International USD -756M 877M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 700M 238M 2025-12
Cooper Companies USD 116.8M 137.4M 2025-09
Dexcom USD 340.7M 40.7M 2025-12
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Globus Medical USD 143.99M 44.18M 2025-09
Inogen USD -6.06M 467K 2024-09
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD 4.31M 11.13M 2025-12
J&J USD 7.82B 2.86B 2026-03
Masimo USD 74.9M 19.5M 2025-09
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 51.06M 22.12M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Solventum Corp USD 332M 179M 2025-12
Stryker USD 1.7B 676M 2025-12
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
West Pharmaceutical Services USD 161.5M 8.6M 2025-12
Zimmer Biomet Holdings USD 98M 320.7M 2025-12